Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NBIX
NBIX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NBIX News
Investigations into Multiple Medical Company Mergers
5d ago
Globenewswire
Neurocrine's INGREZZA Shows Superior Treatment Persistence in Real-World Analysis
5d ago
NASDAQ.COM
INGREZZA Shows Superior Treatment Persistence in Tardive Dyskinesia
6d ago
PRnewswire
INGREZZA Shows Superior Treatment Continuation Compared to AUSTEDO XR
6d ago
Newsfilter
NEUROCRINE BIOSCIENCES INC: OPPENHEIMER INCREASES TARGET PRICE TO $220, UP FROM $192
Apr 07 2026
moomoo
Neurocrine Acquires Soleno for $2.9 Billion
Apr 06 2026
stocktwits
Soleno Therapeutics Acquired by Neurocrine, Shares Surge 32%
Apr 06 2026
Fool
Neurocrine Acquires Soleno for $2.9 Billion
Apr 06 2026
NASDAQ.COM
Investigation Alerts for Multiple Company Mergers
Apr 06 2026
Globenewswire
AppLovin Shares Surge 5% on Bullish Wall Street Reports
Apr 06 2026
CNBC
Soleno Therapeutics Soars 26% on Acquisition Talks with Neurocrine Biosciences
Apr 06 2026
Yahoo Finance
Neurocrine Acquires Soleno for $2.9 Billion to Expand Rare Disease Portfolio
Apr 06 2026
stocktwits
Soleno Shares Surge 30% Amid Acquisition Talks
Apr 06 2026
Fool
Neurocrine Acquires Soleno for $2.9 Billion, Enhancing Portfolio
Apr 06 2026
NASDAQ.COM
Premarket Movers: Netflix, Soleno, Twilio, and More
Apr 06 2026
CNBC
Neurocrine Acquires Soleno, Launches First Treatment for Prader-Willi Syndrome
Apr 06 2026
PRnewswire
Show More News
